Name: 18th Annual Pharmaceutical and Medical Device Compliance Congress
Start: 11/06/17
End: 11/08/17
Location: Mandarin Oriental

KEYNOTE SPEAKERS

Thomas W. Abrams, RPh, MBA

Director, Office of Prescription Drug Promotion, US Food and Drug Administration, Silver Spring, MD

Leslie Backschies, MA

Supervisor Special Agent and Unit Chief, International Corruption Unit, Federal Bureau of Investigation, Los Angeles, CA

Richard Bistrong, MA

Chief Executive Officer, Front-Line Anti-Bribery LLC, Contributing Editor, FCPA Blog, Former Confidential Human Source (CHS) and Cooperating Witness, FBI and US DOJ, Former Cooperating Witness, City of London Police, HMRC and CPS, UK, New York, NY, USA

Hui Chen, JD

Ethics and Compliance Advocate and Consultant, HC Ethics LLC; Former Compliance Counsel Expert (Consultant), US Department of Justice; Former Assistant General Counsel, Pfizer, New York, NY

Zachary A. Cunha, JD

Assistant US Attorney and Chief, Civil Division, US Attorney’s Office, District of Rhode Island, US Department of Justice, Former AUSA, District of Massachusetts and Eastern District of New York, Providence, RI

Susan Dentzer

President and Chief Executive Officer, NEHI, (The Network for Excellence in Health Innovation), Analyst on Health Policy, The NewsHour, Former Editor, Health Affairs, Washington, DC

Jacob Elberg, JD

Assistant US Attorney, US Attorney’s Office, District of New Jersey, US Department of Justice, Newark, NJ

Christopher B. Harwood, JD

Assistant US Attorney and Chief of the Civil Health Care Fraud Unit, US Attorney’s Office, Southern District of New York, Former Assistant US. Attorney, US Attorney’s Office for the District of Columbia, US Department of Justice, New York, NY

Tarek Helou, Esq.

Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, US Department of Justice, Washington, DC

Rachael Honig, JD

First Assistant US Attorney, US Attorney’s Office for the District of New Jersey, Former Corporate Counsel, Litigation, Celgene, New York, NY

Mary E. Riordan, Esq.

Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services, Washington, DC

Gregg Shapiro, JD

Assistant US Attorney, US Attorney’s Office, District of Massachusetts, US Department of Justice, Boston, MA

Sally Q. Yates, JD

Partner, King and Spalding, Former Acting Attorney General, Former Deputy Attorney General, Former Assistant US Attorney, US Attorney’s Office, Northern District of Georgia, US Department of Justice, Washington, DC

AGENDA-AT-A-GLANCE

WEDNESDAY, NOVEMBER 7

FEATURING AN INVITATION-ONLY CCO ROUNDTABLE

Hosted by PCF and PhRMA CCO Working Group; Featuring Hui Chen, JD, HC Ethics LLC

PRECONFERENCE SESSIONS

Patient Support Programs: Risk and Risk Management Best Practices

Practical Approaches to Handling Investigations

Advanced Strategies in Auditing and Monitoring

Asking the Right Risk Questions to Power your Advanced Analytics Strategy

OPENING PLENARY SESSION

OIG Keynote Address

FDA Keynote Address

Risks Your Risk Assessment Might Miss

Chief Compliance Officer Roundtable

THURSDAY, NOVEMBER 8

MORNING PLENARY SESSION

Annual AUSA Roundtable

Annual Qui Tam Roundtable

DOJ, FBI and SEC FCPA Enforcement Update

MINI SUMMITS

Fostering a Culture of Ethics and Compliance

Global Compliance Function Harmonization

Third Party Lifecycle Management

Annual Medical Device Compliance Roundtable

Dissecting Recent CIAs and Review of Draft Model CIA

Strategies to Measure Effectiveness, Monitor and Report

Managing Promotional Programs and Patient Advocacy Groups

Open Payments: Where Does the Sun Shine Now?

MINI SUMMITS, CONTINUED…

Interactions with Specialty Pharmacy

Is your Board Bored of your Compliance Dashboards?

Next Generation Data Analytics Promotion with Medical Professionals: Avoiding White Coat Marketing

Market Access Compliance Considerations

Global Documentation Framework

R&D: Hidden Risks beyond Clinical Trail Recruitment

Compliance for Small to Mid-size Pharma and Device Companies

Compliance Issues Associated with PBM Relationships

Risk Assessments and Mitigation Plans

“All in Compliance” — Aligning with Your Business Partners

Navigating the Murky Waters of Patient Programs

Compliance for “Evolved” Products, including Aesthetics and Gene Therapy

Best Practice in HCP/HCO Management

Compliance Considerations in Value-based Contracting

Risks and Opportunities related to Medical Affairs

An Interactive Case Study in Effective Crisis Management

Privacy and Cybersecurity Compliance Update, including GDPR

The Compliance Training Revolution

CLOSING PLENARY SESSION

Sally Yates Keynote Address

Patient Support Programs Roundtable

Pharma and Device Pricing and Cost Containment

FRIDAY, NOVEMBER 9

INDUSTRY-ONLY BEST PRACTICES ROUNDTABLE

Featuring AUSA Gregg Shapiro, JD

FEATURED SESSION: ANNUAL CCO ROUNDTABLE WITH

Jill Fallows-Macaluso, JD

Chief Compliance Officer and Vice President, Novo-Nordisk, Princeton, NJ

Indrani M. Lall Franchini, JD

Executive Vice President & Chief Compliance Officer, Alexion Pharmaceuticals, Inc., Former Assistant General Counsel, Pfizer, New York, NY

Jonathon Kellerman

Executive Vice President, Global Chief Compliance Officer, Allergan PLC, Former Partner, PwC, Parsippany, NJ

Puja Leekha, JD

Vice President, Chief Compliance Officer and Corporate Counsel, Corporate Compliance, Lundbeck Pharmaceuticals LLC, Former Division Legal Counsel & Compliance Officer, Stryker Corporation, Deerfield, IL

Lori Queisser

Sr VP and Global CCO, Teva, Former Sr. VP Global Compliance & Business Practices, Schering-Plough, Former VP & CCO, Eli Lilly, Former Co-chair, PCF, Horsham, PA

Paul Silver

Principal, Regulatory & Compliance Life Sciences Leader, Deloitte Advisory, Deloitte, Atlanta, GA (Moderator)

FEATURED FACULTY

James Accumanno, JD

Director Risk, Monitoring and Auditing, Novo Nordisk, Former Associate Counsel, Bayer, Philadelphia, PA

Anthony Alvizu, CPA, EnCE, CFE

Managing Director, Global Risk & Investigations Practice (GRIP), FTI Consulting, Chicago, IL

Eliza L. Andonova, JD

Counsel, Hogan Lovells, Washington, DC

Timothy Ayers, JD, MPH

Vice President, Chief Compliance Officer, Horizon Pharma PLC, Former VP, Chief Compliance Officer, Dendreon, Chicago, IL

Eric Baim, JD

Managing Director, Dovetail Consulting Group, LLC, Former VP, Head of US Compliance, Shire, Boston, MA

Yogesh Bahl, CPA, MBA

Managing Director, Alix Partners, New York, NY

Minna Bak, MBA

Senior Manager, Helio Health Group, New York, NY

Jennifer Barbre, MA

Executive Director, Compliance, Spectrum Pharmaceuticals, Inc., Former Director, Compliance and Ethics Program, Avanir, Irvine, CA

Dennis K. Barnes, JD, MBA, CPA

Vice President, Global Governance, Risk and Compliance, Mayne Pharma, Raleigh-Durham, NC

Scott Bass, JD

Partner and Head, Global Life Sciences Team, Sidley Austin LLP, Chicago, IL

Ann E. Beasley, JD

Director, Life Sciences, Governance, Risk & Compliance, Navigant, Former Senior Vice President, Chief Compliance Officer, Biogen, Boston, MA

Thomas Beimers, JD

Partner, Hogan Lovells, Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS, Minneapolis, MN and Washington, DC

Wanda Bell, CHC

Director HCP Compliance, Nestle Skin Health, Former Director Commercial Compliance, Depomed, Former Director, Compliance, Elan, Fort Worth, TX

John T. Bentivoglio, Esq.

Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice; Washington, DC

Brian A. Bohnenkamp, MHA, JD

Partner, FDA & Life Sciences Practice, King & Spalding LLP, Washington, DC

Christine N. Bradshaw, JD

Vice President, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ

Julianne Brierley

Director, Head of Compliance Learning, Novartis, New York, NY

Katherine Buckley, MBA

Partner, Pharmaceutical and Life Sciences Advisory Practice, PwC, Philadelphia, PA

Terra Buckley, JD

Executive Director, US HCC Business Advisory Center of Excellence, Celgene, Former Head, US Compliance, Helsinn, Summit, NJ

Ed Buthusiem, JD

Managing Director, Berkeley Research Group, Adjunct Professor Of Law, Temple University, Former SVP, R&D Legal Operations & Vaccines, GSK, Devon, PA

Joseph Calarco

Chief Compliance Officer at Neos Therapeutics, Inc., Philadelphia, PA

Christie Camelio

Vice President and US Healthcare Compliance Officer, Celgene, Former Head of Risk Management, Novartis, Summit, NJ

Regina G. Cavaliere, JD

Principal, Regulatory Enforcement & Compliance, Life Sciences Sector, KPMG LLP, Former VP and CCO, Otsuka America, Short Hills, NJ

Nicole Chandonnet, JD

Associate, Covington & Burling, Washington, DC

Katherine Chaurette, JD

Senior Director, Assistant General Counsel, Regeneron Pharmaceuticals, Inc., Boston, MA

William Connelly, JD

Senior Counsel, Amgen; Former Staff Attorney, US DHHS, Washington, DC

Brian Conner

Vice President, Head of Corporate Compliance, Strongbridge Biopharma plc, Trevose, PA

Kellie Branson Combs, JD

Counsel, Ropes & Gray LLP, Washington, DC

Thomas Costa, JD

Member, US Board of Directors, Sanofi; Former Vice President, US Compliance & Ethics, Bristol-Myers Squibb, Washington, DC

Clarissa Crain

Senior Manager, Life Sciences Advisory, Deloitte, Philadelphia, PA

Jill Dailey, MBA, JD

Vice President & Chief Compliance Officer, Incyte, Former AG, Asia Pac Lead, Pfizer, Former Head, US Ethics and Compliance, Novartis, New York, NY

Meenakshi Datta, JD

Partner and Global Co-leader, Healthcare Practice, Sidley Austin LLP, Chicago, IL

Mahnu V. Davar, JD

Partner, Arnold & Porter Kaye Scholer LLP, Lecturer, University of Pennsylvania Law School, Fellow, Salzburg Global Seminar, Washington, DC

BJ D’Avella

Senior Manager, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, Atlanta, GA

Sharon R. Delshad, JD

Director, Compliance and Legal Affairs, Nalpropion, Former Director, Compliance and Legal Affairs, Orexigen Therapeutics, San Diego, CA

Gary Del Vecchio

Health Care CO Cardiovascular & Metabolism, Janssen, Former ED US Pharma Compliance & Ethics, Bristol-Myers Squibb, Former PCF Co-chair, New York, NY

Mark A. DeWyngaert, MBA, PhD

Managing Director, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, New York, NY

Sarah diFrancesca, JD

Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY

Christian A. Dingler

Managing Consultant, Navigant Consulting, Richmond, VA

Stefanie A. Doebler, JD

Of Counsel, Covington & Burling LLP, Washington, DC

Suzanne E. Durrell, JD

Partner, Whistleblower Law Collaborative, Taxpayers Against Fraud Education Fund, 2017 Whistleblower Lawyer of the Year, Boston, MA

Michael Dusseau

Vice President, Compliance Operations, Allergan, Former Vice President, Compliance, Bayer, Former Divisional Compliance Officer, Merck, Madison, NJ

Eileen Erdos

Principal, Forensic and Integrity Services, Ernst & Young LLP, Chicago, IL

Melanie Fagan

HCP Engagement Lead, Medical Affairs Compliance, GlaxoSmithKline, Philadelphia, PA

J. Mark Farrar, CPA, CFE, CFF

Managing Director, Navigant; Former Interim Global Chief Compliance Officer, Beckman Coulter, Atlanta, GA, USA

Margaret Feltz, JD, MA

Vice President, Ethics and Compliance, Purdue Pharma LP, Former PCF Co-chair, Stamford, CN

Alison Fethke, JD

Counsel, Ropes & Gray LLP, Former Division Counsel, Legal, Regulatory and Compliance, AbbVie, Chicago, IL

Kellie Fidler, MBA, PMP

Director, Global Compliance Risk Mitigation & Monitoring Strategy, Bristol-Myers Squibb, Princeton Pike, NJ

Francisco Ribeiro Filho, MBA

Senior Director & Head of US Compliance, Tesaro, Inc., Former Sr. Dir., Corporate Compliance, Biogen, Former Sr. Dir., International Markets, Sandoz, Boston, MA

Paul Fishman, JD

Partner and Head, Crisis Management and Strategic Response Team, Arnold & Porter LLP, Former United States Attorney, District of New Jersey, Washington, DC

Paul Flanagan, JD

Assistant Professor of Law, Thomas R. Kline School of Law, Drexel University, Former Chief Compliance and Privacy Officer, 21st Century Oncology, West Chester, PA

Sarah A. Franklin, JD

Partner, Covington & Burling LLP, Former Attorney, Federal Trade Commission, Washington, DC

Alex Ganz, JD

Senior Manager of Compliance, Aegerion Pharmaceuticals, Former Compliance Manager, Shire and Vertex, Boston, MA

Nereyda Garcia, JD

Global Heath, Ethics and Compliance, Alnylam Pharmaceuticals, Former Sr. Director, Compliance, Biogen Idec, Cambridge, MA

Gary F. Giampetruzzi, Esq.

Partner, Paul Hastings; Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc.; New York, NY

Virginia “Ginny” A. Gibson, JD

Partner, Hogan Lovells LLP, Former First Assistant U.S. Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA

Jonathan Glazier, JD, MBA

Head, Legal Compliance, Philips, Former Sr. Dir., Corporate Compliance and Privacy Officer, Fresenius, Andover, MA

Wendy C. Goldstein, JD

Partner, Health Care and Life Sciences Regulatory Practice, Cooley, LLP, New York, NY

Anthony Greco, MBA

Director, Pharmaceutical & Life Sciences Advisory Services, PwC, Philadelphia, PA

Adam Greene, JD, MPH

Partner and Co-chair, Health Information & HIPAA Practice, Davis Wright Tremaine LLP, Former Senior HIT & Privacy Specialist, OCR, DHHS, Washington, DC

Lillian S. Hardy, JD

Partner, Hogan Lovells LLP, Washington, DC

Patricia J. Harned, PhD

Chief Executive Officer, ECI (Ethics and Compliance Initiative), Former President, Ethics Resource Center, Washington, DC

Kate Heinzelman, JD

Counsel, Sidley Austin LLP, Former Deputy GC, US DHHS, Former Special Assistant and Associate Counsel, President Barack Obama, Washington, DC

Laura G. Hoey, JD

Co-leader, Government Enforcement and White Collar Group and Health Care and Life Sciences Industry Group, Ropes & Gray LLP, Chicago, IL

Christine Hood

Director, Learning and Development, Chiesi, Former District Sales Manager, Boehringer Ingelheim, Former Sales Trainer, Biovail, Apex, NC

David Horowitz, JD

Partner, Hogan Lovells LLP, Former Deputy General Counsel, DHHS, Washington, DC

Casey J. Horton, CFE

Director, Life Sciences, Governance, Risk & Compliance, Navigant, Chicago, IL

Emily Huebener, MA

Forensic and Integrity Services, Ernst & Young LLP, Chicago, IL

Erinn Hutchinson

Partner, Advisory Services, PwC, Philadelphia, PA

Michael Joachim, JD

Global Business Partner, Ethics & Business Integrity, Sanofi Genzyme, Cambridge, MA

Elizabeth Jobes, JD

Head, Corporate Compliance & Legal Counsel, Spark, Former Senior VP & CCO, Auxilium, Former PCF Co-chair, Philadelphia, PA

Darren R. Jones

Partner, Global Compliance Consulting Leader, Polaris Management, New York, NY

Marci Juneau, MBA

Partner, Helio Health Group, Atlanta, GA

Kiley Smith Kelly, MBA

Partner, Forensic and Integrity Services, Ernst & Young LLP, Philadelphia, PA

Keith M. Korenchuk, JD, MPH

Partner, Arnold & Porter LLP, Washington, DC

Daniel A. Kracov, JD

Partner, Arnold & Porter Kaye Scholer LLP, Washington, DC

Daryl Kreml, JD

VP & CCO, Sage, Former Head, US Compliance & Global Program Management, Biogen, Former Dir. & Sen. Managing Counsel, Int’l Compliance, Boston Scientific, Boston, MA

Bharathram Lakshmivarahan, MBA

Life Sciences Strategy & Operations Consultant, PwC, San Francisco, CA

Marc Levine

Director of Compliance, Insightec, Former Compliance Officer, Stryker Corporation, Former Business Conduct Specialist, MAKO Surgical, Fort Lauderdale, FL

Jonathan Levy, JD

Corporate Compliance Counsel, Spark Therapeutics; Former Associate Director of Compliance and Ethics, US Pharmaceuticals, Bristol-Myers Squibb; Philadelphia, PA

Jodi Lindsey, JD

Senior Director & Head of US Healthcare Compliance, Alkermes, Former Associate Director, Commercial Compliance, Biogen, Boston, MA

Richard Liner, JD

Senior Counsel, Compliance and Investigations, Bayer, Whippany, NJ

Chad Londeree

Healthcare Industry Group Leader, SAI Global, Richmond, VA

Pamela Lonzer, MSJ

Ass. Dir., Medical Operations, Compliance & Controls, Alexion, Former Ass. Dir. & US Medical Advisor, Global Compliance & Risk Management, Shire, Chicago, IL

Seth H. Lundy, JD

Partner, King & Spalding, Washington, DC

Ali Lyons

Director, Ethics and Compliance, Aegerion Pharmaceuticals; Former Operations Lead, Ethics and Compliance, Eli Lilly and Company, Cambridge, MA

Joe Mack, JD

Senior Compliance Counsel, Bayer, Former Assistant United States Attorney and Deputy Chief, Health Care and Government Fraud Unit, US Attorney’s Office, District of New Jersey, New York, NY

Stephanie Macholtz, JD, MBA

Director, Compliance and Ethics, Global Medical Affairs and Business Development, Alexion Pharmaceuticals, Inc.; Former Compliance Officer, Biogen, Boston, MA

Colette G. Matzzie, JD

Partner, Phillips & Cohen LLP, Former Civil Appellate Staff and Trial Attorney, Tobacco Litigation Team, US Department of Justice, Washington, DC

Dennis McCloskey, JD

Compliance Officer, Olympus Corporation of the Americas, Former Assistant District Attorney, Homicide Unit, Philadelphia District Attorney’s Office, Philadelphia, PA

Vickie L. McCormick

Vice President, Janssen U.S. Commercial Health, Care Compliance & CIA Operations, Johnson & Johnson, Former Chief Compliance Officer, St. Jude Medical, Titusville, NJ

Jennifer McGee, JD

Vice President and Chief Compliance Officer, Otsuka America Pharmaceutical, Inc., Rockville, MD

Jean McKiernan, MBA

Director, Pharmaceutical and Life Sciences Advisory Practice, PwC, Chicago, IL

Jason P. Mehta, JD

Partner, Bradley Arant Boult Cummings LLP, Former Assistant United States Attorney, US Attorney’s Office for the Middle District of Florida, US Department of Justice, Tampa, FL

Stephanie J. Meltzer, JD

Vice President and Assistant General Counsel, Innovative Health, Pfizer, Former Assistant United States Attorney, United States Attorney’s Office, District of Columbia, US Department of Justice, Boston, MA

Kathleen Meriwether, JD

Principal, Fraud Investigation and Dispute Services, EY, Former Assistant United States Attorney, Eastern District of Pennsylvania, US Department of Justice, Philadelphia, PA

Brian Miller, PhD

Dir. Compliance Training and Documentation, Otsuka, Former Senior Mgr, Learning Technologies, AstraZeneca, Former Ass. Dir. Learning Design & Technology, Merck, Princeton, NJ

Vahan Minassian, JD

Director, US Promotional Monitoring Lead, Pfizer, Philadelphia, PA

Gregory S. Moss, Esq.

Senior Vice President, Deputy General Counsel, Kadmon Corporation, New York, NY

Melissa Murphy, MBA

Senior Compliance Specialist, Office of Ethics & Compliance, Medtronic, Minneapolis, MN

Kamleh J. Nicola, LLB

Partner, Baker & McKenzie LLP, Toronto, Canada

Chrisoula Nikidis

Canadian Head of Compliance and Ethics Solutions, IQVIA; Former Executive Director, Ethics and Compliance, Innovative Medicines Canada, Ottawa, Canada

Katherine Cartwright Norris, MPA

Dir., Berkeley Research Group, Former Sr Dir., Compliance, NSF Health Sciences, Former Dir., Corporate Compliance, Spectranetics, Washington, DC

Adam Oakley

Director, Potomac River Partners, Arlington, VA

Laura C. O’Donnell

Vice President and General Counsel, GE Healthcare, Warsaw, IN

Josh T. O’Harra, MS, JD

Assistant General Counsel, Eli Lilly and Company; Former Sr. Associate, King & Spalding, Washington, DC

Agatha O’Malley, MStPH, JD

Privacy Officer and Senior Counsel, Otsuka Pharmaceuticals (US), Former Director – Head of Privacy, Shire, Philadelphia, PA

David W. Opderbeck, JD

Professor of Law, Seton Hall University Law School; Counsel, Gibbons PC, Newark, NJ

John Patrick Oroho, JD

Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ

Amy Pawloski

Compliance Officer – Operations at Endo Pharmaceuticals, Former Global Lead, Compliance Risk Mitigation and Monitoring Strategy, Bristol-Myers Squibb; Philadelphia, PA

Joe Philipose, JD

Vice President, US & Enterprise Compliance, Alexion, Former Director of Compliance, Salix, Former Director, PwC Life Sciences Consulting, Boston, MA

Roy Pollitt

Managing Director, Americas Head, Investigations, Exiger, Former Special Agent, Federal Bureau of Investigation, New York, NY

Perri Pomper

Director – Ethics and Compliance Strategy & Education at Novo Nordisk

Kelly N. “Nikki” Reeves, MPA, JD

Partner, King & Spalding LLP, Washington, DC

Jeffrey Rosenbaum, MBA

Partner and Co-founder, Dovetail Consulting Group, LLC, Former SVP, Chief Compliance and Risk Officer, Shire, Boston, MA

David Ryan, JD

Vice President and Chief Compliance Officer, Epizyme, Former Vice President, Associate GC and CCO, Haemonetics, Boston, MA

Mark Scallon, MHA

Senior Principal, Polaris, IQVIA Global Compliance, Richmond, VA

Philip Lo Scalzo, JD

Senior Vice President, Chief Compliance Officer, BioMarin; Former Assistant General Counsel, sanofi-aventis, Novato, CA

Cheryl J. Scarboro, JD

Partner, Simpson Thacher & Bartlett, Former, Chief, FCPA Unit, Enforcement Division, US SEC, Washington, DC

Sue Seferian, JD

Health Care Compliance Officer, Johnson & Johnson, Titusville, NJ

George Serafin, MS

National Health Care and Life Sciences Leader, Grant Thornton, LLP, Iselin, NJ

Nicole Serena

Director, Patient Access, Bayer, Canada

Patterson Shafer

Managing Director, Health Care and Life Sciences, Grant Thornton, Stamford, CT

Michael Shaw, JD

Vice President and Compliance Officer, US Pharmaceuticals, GlaxoSmithKline, Former Senior Counsel, Office of Inspector General, US DHHS, Former PCF Co-chair, Philadelphia, PA

Laura (Munns) Skinner, MBA

Senior Manager, Life Sciences Advisory, Deloitte, Austin, TX

John Smollen, MA, JD

Practice Professor of Law and Director, Center for Compliance and Ethics, Temple Law, Former EVP and CCO, Endo International, Philadelphia, PA

Eugene F. Soltes, MBA, PhD

Jakurski Family Associate Professor of Business Administration, Harvard Business School, Author, Why They Do It: Inside the Mind of the White-Collar Criminal, Cambridge, MA

Oliver Steck

Principal, Life Sciences Regulatory and Operational Risk, Deloitte & Touche LLP, New York, NY

Tim Stow, JD

Senior Vice President and Head of Legal International, Shire, Former VP, Head of Legal Europe, International & Asia Pacific, UCB, Boston, MA

Silvija A. Strikis, JD

Partner, Kellogg Hansen Todd, Figel & Frederick, Former Law Clerk, Justice Sandra Day O’Connor, US Supreme Court, Washington, DC

Ravi Tayi, MD, MPH

Chief Medical Officer, US Ferring Pharmaceuticals; Former Vice President, Global Medical Affairs, Mallinckrodt; Former Vice President, Medical Affairs and Clinical Development, Cubist/Optimer, New York, NY

Ann-Marie Tejcek, MA

Senior Director, Ethics & Compliance, Eli Lilly and Company, Indianapolis, IN

Yuet Ming Tham, JD

Partner and Global Head of White Collar Group, Sidley Austin, LLP, Former Asia Pacific Regional Compliance Director, Pfizer, Singapore and Hong Kong

Bryan Timer, MA Business Analytics

Director, Data Analytics & Transparency, Merck, North Wales, PA

Brian Van Hoy

Vice President, G&M Health LLC, Former Director, Ethics and Compliance, Eli Lilly, Bridgewater, NJ

Jennifer Vondee, MPH

Manager, Pharmaceutical & Life Sciences Risk Consulting, PwC, Durham, NC

Julie Ritchie Wagner, JD

Assistant General Counsel, PhRMA; Former Senior Counsel, Office of Counsel to the Inspector General, US DHHS; Washington, DC

Lisa Walkush, EMTM

Partner, Grant Thornton, LLP, Philadelphia, PA

William Weinreb, JD

Partner, Quinn Emanuel, Former Acting United States Attorney and First Assistant US Attorney, Boston, Boston, MA

Sarah Whipple, JD

Senior Corporate and Compliance Counsel, Akebia Therapeutics, Inc., Former VP, Global Compliance & Privacy Officer, Aegerion, Former CCO and Assoc. GC, AMAG, Boston, MA

Donna White

Vice President, Contracts & Compliance, Chiesi USA, Inc., Former Sr. Director, Contracts and Compliance, Cornerstone Therapeutics, Cary, NC

Seth B. Whitelaw, JD, LLM, SJD

President and Chief Executive Officer, Whitelaw Compliance Group, LLC, Editor, Life Science Compliance Update, West Chester, PA

Jonathan Wilkenfeld, MBA

Partner, Potomac River Partners, Washington, DC

Kathryn “Katie” E. Winson

Senior Manager, US HCC Monitoring, Celgene Corporation, Summit, NJ

2018 GLOBAL PHARMA COMPLIANCE CONGRESSES

TWELFTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS

Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
May 14 – 16, 2018
Hotel Savoyen
Vienna, Austria
www.InternationalPharmaCongress.com

EIGHTH ASIA PACIFIC PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS

Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS)
Media Partners: Life Sciences Compliance Update
September 10 – 12, 2018
Singapore
www.AsianPharmaCongress.com

NINETEENTH ANNUAL PHARMACEUTICAL AND
MEDICAL DEVICE COMPLIANCE CONGRESS

A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum (PCF)
November 7 – 9, 2018
Mandarin Oriental
Washington, DC
www.PharmaCongress.com